Neogenomics Inc at Cowen Health Care Conference Transcript
Well, thank you guys for your patience, I really appreciate it. And we're excited to be here to get to tell you a little bit about Neo. My plan is to talk for 15, maybe 20 minutes and then we will take some Q&A. So if you have any questions feel free to let us know.
This is a longer deck than what we had, so I'm going to quickly move through some pages. If there is anything that looks interesting and you want me to stop, feel free to ask questions. Forward-looking statements.
All right, so let me just talk here for a few minutes and just keep this a little bit easy. Before I come to this slide let me tell you a little bit about Neo. Neo started in 2002 with our first CLIA accredited lab. And in 2008 we were at about $20 million of revenue. And then fast-forward 10 years, we finished last year with $272 million in revenue.
So we are a growth story for sure. We went through organic growth all the way up to 2015, 2016 and we made a major acquisition of Clarient out of GE. And so, was the legacy Neo business coupled with Clarient.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |